Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial
Crossref DOI link: https://doi.org/10.1186/s12894-017-0243-1
Published Online: 2017-07-03
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peabody, John W. https://orcid.org/0000-0002-0210-9232
DeMaria, Lisa M.
Tamondong-Lachica, Diana
Florentino, Jhiedon
Czarina Acelajado, M.
Ouenes, Othman
Richie, Jerome P.
Burgon, Trever
Funding for this research was provided by:
Metamark Genetics